Unique ID issued by UMIN | UMIN000034446 |
---|---|
Receipt number | R000039279 |
Scientific Title | The evaluation of a one-day Acceptance and Commitment Therapy workshop and workbook for the people who have irritable bowel syndrome symptoms |
Date of disclosure of the study information | 2018/10/12 |
Last modified on | 2020/04/23 10:00:07 |
The evaluation of a one-day Acceptance and Commitment Therapy workshop and workbook for the people who have irritable bowel syndrome symptoms
The evaluation of ACT for irritable bowel syndrome symptoms
The evaluation of a one-day Acceptance and Commitment Therapy workshop and workbook for the people who have irritable bowel syndrome symptoms
The evaluation of ACT for irritable bowel syndrome symptoms
Japan |
irritable bowel syndrome
Gastroenterology | Psychosomatic Internal Medicine | Psychiatry |
Adult |
Others
NO
The purpose of this study is whether brief group Acceptance and Commitment Therapy workshop and workbook could demonstrate significant decrease in irritable bowel syndrome severity
Efficacy
Irritable bowel syndrome severity index (IBSSI-J)
measuring at before intervention, 2 month and 4 month later the workshop.
1.The Japanese version of the irritable bowel syndrome quality of life instrument (IBS-QOL-J)
2.Medical Outcome Study 36-item Short Form Health Survey (SF-36)
3.Beck Depression Inventory-Second Edition (BDI-2)
4.State Trait Anxiety Inventory (STAI)
5. The Japanese version of the Acceptance and Action Questionnaire-II
6. The Japanese version of the Cognitive Fusion Questionnaire
7. The Japanese version of the Five Facet Mindfulness Questionnaire
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
Numbered container method
2
Educational,Counseling,Training
Behavior,custom |
one-day workshop of Acceptance and Commitment Therapy and workbook of Acceptance and Commitment Therapy
Waiting
18 | years-old | <= |
50 | years-old | > |
Male and Female
1.The score of IBSSI >= 75 at the screening survey.
2.Ability to both understand and agree with informed consent in Japanese
1.Participants who presently undergoing psychopharmacological, or psychological treatment for gastrointestinal or psychiatric disorder
2.Person in whom organic disease is suggested by the presence of warning symptom (anemia, inflammatory reactions, or fecal occult blood, Unexplained weight loss in past 6 months, Persons with a family history of colon cancer)
3.Persons observed to have significant suicidal ideation
4.Any other person whom the principal investigator has determined to be unsuitable as a participant of the study
70
1st name | Takashi |
Middle name | |
Last name | Muto |
Doshisha university
Faculty of psychology
6100394
1-3 Miyakodani, Tatara, Kyotanabe, Kyoto
0774658220
takamuto@mail.doshisha.ac.jp
1st name | Masataka |
Middle name | |
Last name | Ito |
Doshisha university
Graduate school of Psychology
6100394
1-3 Miyakodani, Tatara, Kyotanabe, Kyoto
0774658220
ekq1003@mail2.doshisha.ac.jp
Doshisha University
Doshisha University
Other
Doshisha University Research Ethics Committee
1-3 Miyakodani, Tatara, Kyotanabe, Kyoto
0752513158
ji-rinri@mail.doshisha.ac.jp
NO
2018 | Year | 10 | Month | 12 | Day |
Unpublished
Completed
2018 | Year | 07 | Month | 10 | Day |
2018 | Year | 07 | Month | 10 | Day |
2018 | Year | 10 | Month | 12 | Day |
2020 | Year | 03 | Month | 31 | Day |
2018 | Year | 10 | Month | 11 | Day |
2020 | Year | 04 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039279